Clinical Trial Update: Intranasal Dexmedetomidine and Zolpidem for Treatment of Primary Insomnia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating intranasal dexmedetomidine and zolpidem for treatment of primary insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Dexmedetomidine (intranasal) (dexmedetomidine)
• Zolpidem (zolpidem)

Snippet

Sponsor: The University of Hong Kong | Conditions: Insomnia | Phase 3 | Status: UNKNOWN